Chung-Chi Hsu

4PUBLICATIONS
17CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Apr 07, 2025
Emerging Roles of ACTL6A as an Oncogenic Hub: Transcriptional Regulation and Beyond.

Kelvin K Tsai, Li-Hsin Cheng, Chung-Chi Hsu

|Jun 29, 2023
Oncogenic ASPM Is a Regulatory Hub of Developmental and Stemness Signaling in Cancers.

Kelvin K Tsai, Byoung-Il Bae, Chung-Chi Hsu

|Jan 13, 2023
ASPM Activates Hedgehog and Wnt Signaling to Promote Small Cell Lung Cancer Stemness and Progression.

Li-Hsin Cheng, Chung-Chi Hsu, Hung-Wen Tsai

|Nov 25, 2016
Metronomic chemotherapy prevents therapy-induced stromal activation and induction of tumor-initiating cells.

Tze-Sian Chan, Chung-Chi Hsu, Vincent C Pai

Pageof 1